|
06/06/2011 - Tragara
to Present TG01 Poster at the ASCO 2011 Annual Meeting
"Patients Pathways Progress"
Dr. Sara Zaknoen, Chief Medical officer Tragara Pharmaceuticals
Inc.,
will
present a poster during the ASCO Annual Meeting “Patients
Pathways Progress” in Chicago, Illinois.
“APRiCOT-L:
Results of a Biomarker Based Phase II Randomized Placebo-Controlled
Study of Apricoxib in Combination with Erlotinib in Non-Small
Cell Lung Cancer (NSCLC) Patients”
Category: Lung Cancer – Metastatic/Non-small Cell
Session: Monday, June 6, 2011, 2:00 – 6:00 PM
Venue: McCormick Convention Center, Hall D2, E450a
Abstract #
7258
Poster Board #: 17
|
